Prior Vancomycin Use Is a Risk Factor for Reduced Vancomycin Susceptibility in Methicillin-Susceptible but Not Methicillin-Resistant Staphylococcus aureus Bacteremia

被引:9
作者
Mascitti, Kara B. [1 ]
Edelstein, Paul H. [2 ]
Fishman, Neil O. [3 ,4 ]
Morales, Knashawn H. [5 ,6 ]
Baltus, Andrew J. [2 ]
Lautenbach, Ebbing [3 ,4 ,5 ,6 ]
机构
[1] St Lukes Hosp & Hlth Network, Dept Med, Div Infect Dis, Bethlehem, PA 18015 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
BACTERICIDAL ACTIVITY; FITNESS COST; MIC VALUES; IMPACT; DAPTOMYCIN; EFFICACY; ASSOCIATION; INFECTIONS; MORTALITY; FAILURE;
D O I
10.1086/663708
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. Staphylococcus aureus is a cause of community-and healthcare-acquired infections and is associated with substantial morbidity, mortality, and costs. Vancomycin minimum inhibitory concentrations (MICs) among S. aureus have increased, and reduced vancomycin susceptibility (RVS) may be associated with treatment failure. We aimed to identify clinical risk factors for RVS in S. aureus bacteremia. DESIGN. Case-control. SETTING. Academic tertiary care medical center and affiliated urban community hospital. PATIENTS. Cases were patients with RVS S. aureus isolates (defined as vancomycin E-test MIC >1.0 mu g/mL). Controls were patients with non-RVS S. aureus isolates. RESULTS. Of 392 subjects, 134 (34.2%) had RVS. Fifty-eight of 202 patients (28.7%) with methicillin-susceptible S. aureus (MSSA) isolates had RVS, and 76 of 190 patients (40.0%) with methicillin-resistant S. aureus (MRSA) isolates had RVS (P = .02). In unadjusted analyses, prior vancomycin use was associated with RVS (odds ratio [OR], 2.08; 95% confidence interval [CI], 1.00-4.32; P = .046). In stratified analyses, there was significant effect modification by methicillin susceptibility on the association between vancomycin use and RVS (P = .04). In multivariable analyses, after hospital of admission and prior levofloxacin use were controlled for, the association between vancomycin use and RVS was significant for patients with MSSA infection (adjusted OR, 4.02; 95% CI, 1.11-14.50) but not MRSA infection (adjusted OR, 0.87; 95% CI, 0.36-2.13). CONCLUSIONS. A substantial proportion of patients with S. aureus bacteremia had RVS. The association between prior vancomycin use and RVS was significant for patients with MSSA infection but not MRSA infection, suggesting a complex relationship between the clinical and molecular epidemiology of RVS in S. aureus. Infect Control Hosp Epidemiol 2012;33(2):160-166
引用
收藏
页码:160 / 166
页数:7
相关论文
共 41 条
[1]  
Bannerman TL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P390
[2]  
Biodisk A, E TEST TECHN MAN
[3]   Colonization with Multiple Staphylococcus aureus Strains among Patients in European Intensive Care Units [J].
Bloemendaal, A. L. A. ;
Fluit, A. C. ;
Jansen, W. T. M. ;
Vriens, M. R. ;
Ferry, T. ;
Amorim, J. M. ;
Pascual, A. ;
Stefani, S. ;
Papaparaskevas, J. ;
Rinkes, I. H. M. Borel ;
Verhoef, J. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (09) :918-920
[4]  
Clinical and Laboratory Standards Institute, 2006, M100S16 CLSI
[5]  
Clinical Laboratory Standards Institute, 2006, M7A7 CLSI
[6]  
CLSI Clinical and Laboratory Standards Institute, 2008, CLSI document M100-S18
[7]   The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174
[8]   Fitness cost of SCCmec and methicillin resistance levels in staphylococcus aureus [J].
Ender, M ;
McCallum, N ;
Adhikari, R ;
Berger-Bächi, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2295-2297
[9]   Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S-aureus [J].
Fitzgibbon, Margaret M. ;
Rossney, Angela S. ;
O'Connell, Brian .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (10) :3263-3269
[10]   Fluoroquinolone-resistant Pseudomonas aeruginosa:: Assessment of risk factors and clinical impact [J].
Gasink, Leanne B. ;
Fishman, Neil O. ;
Weiner, Mark G. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Lautenbach, Ebbing .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (06) :526.e19-526.e25